Breakthrough Therapy

A Breakthrough Therapy designation is a status given by the FDA to drugs that show they may offer significant improvements over existing treatments for serious or life-threatening conditions. This status helps expedite the drug’s development and review process, allowing patients to access promising new medicines more quickly. It is granted when early clinical evidence suggests the drug could provide substantial benefits, encouraging faster innovation while still maintaining rigorous safety and effectiveness evaluations.